Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Ran Duan's publication output changed over time?
ScholarIQpublication output · 2015–2023
Output declined50% over the shown period — from 2 works in 2015 to 1 in 2023.
2
2
3
1
1
1
1
2015201620172020202120222023
What are the most-cited papers on Ran Duan?
ScholarIQmost cited works
Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US
Magaly Perez‐Nieves, Samaneh Kabul, Urvi Desai, Jasmina Ivanova, Noam Y. Kirson, Alice Kate G. Cummings, Howard G. Birnbaum, Ran Duan, Dachuang Cao, Irene Hadjiyianni
Current Medical Research and Opinion. 201548 CitationsOPEN ACCESS
Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer
Ran Duan, Xiaoqin Li, Dongqiang Zeng, Xiaofeng Chen, Bo Shen, Dongqin Zhu, Liuqing Zhu, Yangyang Yu, Deqiang Wang
Frontiers in Immunology. 202127 CitationsOPEN ACCESS
FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial
Xiaowei Zhang, Ran Duan, Yusheng Wang, Xin Liu, Wen Zhang, Xiaodong Zhu, Zhiyu Chen, Wei Feng Shen, Yifu He, Hongqiang Wang, Mingzhu Huang, Chenchen Wang, Zhe Zhang, Xiaoying Zhao, Li‐Xin Qiu, Jianfeng Luo, Xuedan Sheng, Weijian Guo
S41085503. 202226 CitationsOPEN ACCESS
Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial
Samaneh Kabul, Robert C. Hood, Ran Duan, Amy M. DeLozier, Julie Settles
Health and Quality of Life Outcomes. 201620 CitationsOPEN ACCESS
Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> )
Simon Heller, Richard E. Pratley, Alan J. Sinclair, Andreas Festa, Jacek Kiljański, Cynthia Brusko, Ran Duan, Robert J. Heine
Diabetes Obesity and Metabolism. 201720 CitationsOPEN ACCESS
Related on ScholarIQ
Shenyang Agricultural University
Institution
Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US
Paper
Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer
Paper
FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial
Paper
Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial
Paper
Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> )
Paper